Authors:
DECAUDIN D
BOSQ J
TERTIAN G
NEDELLEC G
BENNACEUR A
VENUAT AM
BAYLE C
CARDE P
BENDAHMANE B
HAYAT M
MUNCK JN
Citation: D. Decaudin et al., PHASE-II TRIAL OF FLUDARABINE MONOPHOSPHATE IN PATIENTS WITH MANTLE-CELL LYMPHOMAS, Journal of clinical oncology, 16(2), 1998, pp. 579-583
Authors:
RIBRAG V
NASR F
BOUHRIS JH
BOSQ J
BRAULT P
GIRINSKY T
COSSET JM
MUNCK JN
CORTI C
DECAUDIN D
PICO JL
HAYAT M
CARDE P
Citation: V. Ribrag et al., VIP (ETOPOSIDE, IFOSFAMIDE AND CISPLATINUM) AS A SALVAGE INTENSIFICATION PROGRAM IN RELAPSED OR REFRACTORY HODGKINS-DISEASE, Bone marrow transplantation, 21(10), 1998, pp. 969-974
Authors:
VERGIER B
BEYLOTBARRY M
PULFORD K
MICHEL P
BOSQ J
DEMURET A
BEYLOT C
DELAUNAY MM
AVRIL MF
DALAC S
BODEMER C
JOLY P
GROPPI A
DEMASCAREL A
BAGOT M
MASON DY
WECHSLER J
MERLIO JP
Citation: B. Vergier et al., STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS ), The American journal of surgical pathology, 22(10), 1998, pp. 1192-1202
Authors:
SOCIE G
SCIEUX C
GLUCKMAN E
SOUSSI T
CLAVEL C
SAULNIER P
BIREMBAULT P
BOSQ J
MORINET F
JANIN A
Citation: G. Socie et al., SQUAMOUS-CELL CARCINOMAS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONFOR APLASTIC-ANEMIA - FURTHER EVIDENCE OF A MULTISTEP PROCESS, Transplantation, 66(5), 1998, pp. 667-670
Citation: J. Viala et al., SINEREM MR COMPARED TO PLAIN MRI IN THE DETECTION OF HEAD AND NECK METASTATIC LYMPH-NODES - PRELIMINARY-RESULTS OF A PHASE-III CLINICAL-TRIAL, Radiology, 209P, 1998, pp. 778-778
Authors:
VIEGAS LC
PARISE O
TALBOT M
KOWALSKI LP
LUBOINSKI B
JANOT F
BOSQ J
Citation: Lc. Viegas et al., LOSS OF C-ERB-B2 EXPRESSION AND TUMOR PROGRESSION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA (HNSCC), British Journal of Cancer, 77, 1998, pp. 127-127
Authors:
JANOT F
GUERRY M
VABRE L
TALBOT M
LERIDANT AM
MAMELLE G
HILL C
BOSQ J
LUBOINSKI B
Citation: F. Janot et al., ABSENCE OF C-ERB-B2 EXPRESSION AND RISK OF DISTANT METASTASIS IN PHARYNGEAL TUMORS, British Journal of Cancer, 77, 1998, pp. 128-128
Authors:
ARNULF B
COPIEBERGMAN C
DELFAULARUE MH
LAVERGNESLOVE A
BOSQ J
WECHSLER J
WASSEF M
MATUCHANSKY C
EPARDEAU B
STERN M
BAGOT M
REYES F
GAULARD P
Citation: B. Arnulf et al., NONHEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A SUBSET OF CYTOTOXIC LYMPHOMAS WITH MUCOSAL OR SKIN LOCALIZATION, Blood, 91(5), 1998, pp. 1723-1731
Authors:
FORTIN A
GUERRY M
GUERRY R
TALBOT M
PARISE O
SCHWAAB G
BOSQ J
BOURHIS J
SALVATORI P
JANOT F
BUSSON P
Citation: A. Fortin et al., CHROMOSOME 11Q13 GENE AMPLIFICATIONS IN ORAL AND OROPHARYNGEAL CARCINOMAS - NO CORRELATION WITH SUBCLINICAL LYMPH-NODE INVASION AND DISEASERECURRENCE, Clinical cancer research, 3(9), 1997, pp. 1609-1614
Authors:
DECAUDIN D
BOSQ J
MUNCK JN
BAYLE C
KOSCIELNY S
BOUDJEMAA S
BENNACEUR A
VENUAT AM
NACCACHE P
BENDAHMANE B
RIBRAG V
CARDE P
PICO JL
HAYAT M
Citation: D. Decaudin et al., MANTLE CELL LYMPHOMAS - CHARACTERISTICS, NATURAL-HISTORY AND PROGNOSTIC FACTORS OF 45 CASES, Leukemia & lymphoma, 26(5-6), 1997, pp. 539
Authors:
CARAYOL G
BOURHIS JH
GUILLARD M
BOSQ J
PAILLER C
CASTAGNA L
VERNANT JP
PICO JL
HAYAT M
CHOUAIB S
CAIGNARD A
Citation: G. Carayol et al., QUANTITATIVE-ANALYSIS OF T-HELPER-1, T-HELPER-2, AND INFLAMMATORY CYTOKINE EXPRESSION IN PATIENTS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - RELATIONSHIP WITH THE OCCURRENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, Transplantation, 63(9), 1997, pp. 1307-1313
Authors:
LASSAU N
LECLERE J
AUPERIN A
BOURHIS JH
HARTMANN O
VALTEAUCOUANET D
BENHAMOU E
BOSQ J
IBRAHIM A
GIRINSKI T
PICO JL
ROCHE A
Citation: N. Lassau et al., HEPATIC VENOOCCLUSIVE DISEASE AFTER MYELOABLATIVE TREATMENT AND BONE-MARROW TRANSPLANTATION - VALUE OF GRAY-SCALE AND DOPPLER US IN 100 PATIENTS, Radiology, 204(2), 1997, pp. 545-552
Authors:
CARCELAIN G
ROUASFREISS N
ZORN E
CHUNGSCOTT V
VIEL S
FAURE F
BOSQ J
HERCEND T
Citation: G. Carcelain et al., IN-SITU T-CELL RESPONSES IN A PRIMARY REGRESSIVE MELANOMA AND SUBSEQUENT METASTASES - A COMPARATIVE-ANALYSIS, International journal of cancer, 72(2), 1997, pp. 241-247
Authors:
GIRINSKY T
RIBRAG V
BOSQ J
KOSCIENLY S
MUNCK JN
CARDE P
PICO JL
LUBIN R
BOURHIS JH
DELARUE P
Citation: T. Girinsky et al., PREDICTIVE VALUE OF SERUM P53 ANTIBODIES IN PATIENTS WITH LARGE-CELL LYMPHOMAS RETROSPECTIVE ANALYSIS OF 40 PATIENTS, Blood, 90(10), 1997, pp. 3896-3896
Authors:
RIBRAG V
TOUITOU R
BOSQ J
KOSCIELNY S
OUABDESSELAM R
NASR F
CORTI C
BRAULT P
CARDE P
HAYAT M
JOAB I
PALLARDY M
Citation: V. Ribrag et al., HIGH SERUM INTERLEUKIN-2 RECEPTOR AND INTERLEUKIN-6 LEVELS ARE ASSOCIATED WITH A POOR FREEDOM FROM PROGRESSION IN ADULT NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 3945-3945
Authors:
ARNULF B
COPIEBERGMAN C
DELFAULARUE MH
LAVERGNESLOVE A
BOSQ J
WECHSLER J
WASSEF M
MATUCHANSKY C
EPARDEAU B
STERN M
BAGOT M
REYES F
GAULARD P
Citation: B. Arnulf et al., NON HEPATOSPLENIC GAMMA-DELTA T-CELL LYMPHOMA - A SUBSET OF CYTOTOXICLYMPHOMAS WITH MUCOSAL OR SKIN LOCALIZATION, Blood, 90(10), 1997, pp. 1509-1509
Authors:
BOURHIS J
LUBIN R
ROCHE B
KOSCIELNY S
BOSQ J
DUBOIS I
TALBOT M
MARANDAS P
SCHWAAB G
WIBAULT P
LUBOINSKI B
ESCHWEGE F
SOUSSI T
Citation: J. Bourhis et al., ANALYSIS OF P53 SERUM ANTIBODIES IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of the National Cancer Institute, 88(17), 1996, pp. 1228-1233
Authors:
MUNCK JN
DHERMAIN F
KOSCIELNY S
GIRINSKY T
CARDE P
BOSQ J
DECAUDIN D
JULIERON M
COSSET JM
HAYAT M
Citation: Jn. Munck et al., ALTERNATING CHEMOTHERAPY AND RADIOTHERAPY FOR LIMITED-STAGE INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMAS - LONG-TERM RESULTS FOR 96 PATIENTS WITH TUMORS GREATER-THAN-5 CM, Annals of oncology, 7(9), 1996, pp. 925-931
Authors:
CVITKOVIC E
ESCHWEGE F
RAHAL M",DOSEN,"MERSIC Z
KRAJINA Z
ARMAND JP
BOUHRIS J
TUBIANAMATHIEU M
FOUNTZILAS G
KOSMIDIS PA
PRASAD U
GANESAN S
ELGUEDDARI B
BACHOUCHI M
MANSOURI A
OLIVEIRA J
RAPOSO J
WIERZBICKI R
LIANES P
PENA C
ONAT H
ALTUN M
BENHAMOU E
DUCOURTIEUX M
AZLI N
FANDI A
TAAMMA A
BOSQ J
KLIJANIENKO J
SIGAL R
HONG WK
VOKES EE
CLARK JR
LEFLOCH O
BERNIER J
Citation: E. Cvitkovic et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING NEOADJUVANT CHEMOTHERAPY (CISPLATIN, EPIRUBICIN, BLEOMYCIN) PLUS RADIOTHERAPY VS RADIOTHERAPY ALONE IN STAGE-IV (GREATER-THAN-OR-EQUAL-TO-N2, M0) UNDIFFERENTIATED NASOPHARYNGEAL CARCINOMA - A POSITIVE EFFECT ON PROGRESSION-FREESURVIVAL, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 463-469
Authors:
BOURHIS J
DENDALE R
HILL C
BOSQ J
JANOT F
ATTAL P
FORTIN A
MARANDAS P
SCHWAAB G
WIBAULT P
MALAISE EP
BOBIN S
LUBOINSKI B
ESCHWEGE F
WILSON G
Citation: J. Bourhis et al., POTENTIAL DOUBLING TIME AND CLINICAL OUTCOME IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA TREATED WITH 70 GY IN 7 WEEKS, International journal of radiation oncology, biology, physics, 35(3), 1996, pp. 471-476